Ospemifene binds to estrogen receptors in various tissues. In the vaginal tissues, it mimics the actions of estrogen, which helps in alleviating symptoms of VVA such as vaginal dryness, irritation, and dyspareunia. By maintaining the vaginal epithelium, it reduces the thinning and inflammation associated with low estrogen levels in postmenopausal women.
